相关实验视频

Updated: Jun 22, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

一种独特的mRNA疫苗引起了对SARS-CoV-2Omicron变种和SARS-CoV的保护效果

Xiaoqing Guan¹, Abhishek K Verma², Gang Wang¹

¹Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.

|June 27, 2024

概括

一种使用保存SARS-CoV RBD的新型mRNA疫苗显示出对SARS-CoV-2变种和SARS-CoV的承诺. 这种疫苗引起强烈的免疫反应,并保护小鼠免受感染,为更广泛的冠状病毒保护提供了潜力.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
疫苗开发疫苗开发

背景情况:

高致病性冠状病毒SARS-CoV-2和SARS-CoV导致全球卫生危机.
在SARS-CoV-2 Omicron变种的尖端蛋白 RBD 中的突变降低了当前疫苗的疗效.
需要针对正在演变的SARS-CoV-2和相关冠状病毒进行广泛的保护性疫苗.

研究的目的:

设计和评估针对SARS-CoV-2变种和SARS-CoV.的新型mRNA疫苗.
评估两种不同的mRNA疫苗候选人的免疫性和保护效果.

主要方法:

开发了两种脂质纳米粒子封装的mRNA疫苗:SARS2-S (RBD-del) 和SARS2-S (SARS-RBD). 公司的产品包括:
在不同温度下评估疫苗的稳定性.
在体外评估T细胞反应,抗体产生和中和抗体标位.
在与SARS-CoV-2 Omicron和SARS-CoV.挑战的小鼠模型中测试了保护功效.

主要成果:

SARS2-S (SARS-RBD) mRNA表现出稳定性,并引起了强大的T细胞反应和针对SARS-CoV-2和SARS-CoV RBDs的强有力的抗体.
这种疫苗诱导了强大的中和抗体,通过降低肺病毒标位来保护小鼠免受SARS-CoV-2的Omicron挑战,并完全防止了SARS-CoV诱导的体重减轻和死亡.
来自SARS2-S (SARS-RBD) 免疫小鼠的血清抗体给予了对SARS-CoV挑战的保护.

结论:

在SARS2-S (SARS-RBD) 的mRNA疫苗是稳定的和免疫的.
这种候选疫苗显示出针对SARS-CoV-2变种和SARS-CoV.的广泛保护的巨大潜力.
这种mRNA疫苗的进一步开发可以有效地保护当前和未来与SARS相关的冠状病毒威胁.

关键词:

在 COVID-19 疫情中,这就是SARS-CoV.这就是SARS-CoV-2病毒.冠状病毒冠状病毒病毒受体结合域是一个受体结合域.尖子蛋白质是什么?这是一种独特的mRNA疫苗.

更多相关视频

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

相关概念视频

Nuclear Export of mRNA

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...